Neurology Specific Literature Search   
 
[home][thesaurus]
    
Click Here to return To Results

 

Valvular Heart Disease Associated with Fenfluramine-Phentermine
NEJM 337:581-588, 629, 635, 63697., Connolly,H.M.,et al, 1997
See this aricle in Pubmed

Article Abstract
Twenty-four women,mean age 44.8 years,were evaluated for 12.3 months after the initiation of fenfluramine-phentermine therapy.Echocardiography demonstrated unusual valvular morphology and regurgitation in all patients.Both right-sided and left-sided heart valves were involved.Eight women also had newly documented pulmonary hypertension.To date,cardiac surgical intervention has been required in five patients.The heart valves had a glistening white appearance.Histopathologic findings included plaque-like encasement of the leaflets and chordal structures with intact heart valve architecture.The histopathologic features were identical to those seen in carcinoid or ergotamine-induced valve disease.These cases arouse concern that fenfluramine-phentermine therapy may be associated with valvular heart disease.Candidates for fenfluramine-phentermine therapy should be informed about serious potential adverse effects, including pulmonary hypertension and valvular heart disease.
 
Related Tags
(click to filter results - removes previous filter)

adverse drug reaction
anorectics
aortic valve,lesion of
echocardiogram
fenfluramine
heart murmur
mitral valve lesion
mitral valve regurgitation
phen-fen
phentermine
pulmonary hypertension
serotonin
tricuspid valve,lesion of
weight loss

Click Here to return To Results